Duchenne Muscular Dystrophy [E-Book] : Methods and Protocols / edited by Camilla Bernardini.
This volume explores experimental approaches used to study Duchenne muscular dystrophy (DMD), an X-linked degenerative skeletal muscle disease caused by mutations in the dystrophin gene. Including the latest progress and scientific achievements, the book covers recent discoveries achieved through in...
Saved in:
Full text |
|
Personal Name(s): | Bernardini, Camilla, editor |
Imprint: |
New York, NY :
Humana Press,
2018
|
Physical Description: |
XII, 288 p. 49 illus., 34 illus. in color. online resource. |
Note: |
englisch |
ISBN: |
9781493973743 |
DOI: |
10.1007/978-1-4939-7374-3 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
Methods in molecular biology ;
1687 |
Subject (ZB): | |
Subject (LOC): | |
Classification: |
- An Overview of Recent Therapeutics Advances for Duchenne Muscular Dystrophy.-Clinical Manifestations and Overall Management Strategies for Duchenne Muscular Dystrophy
- Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies
- Characterization of the Inflammatory Response in Dystrophic Muscle Using Flow Cytometry
- Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle
- System Biology Approach: Gene Network Analysis for Muscular Dystrophy
- Proteomic Profiling of the Dystrophin-Deficient Brain
- Probing the Pathogenesis of Duchenne Muscular Dystrophy Using Mouse Models
- Exon Skipping Therapy Using Phosphorodiamidate Morpholino Oligomers in the mdx52 Mouse Model of Duchenne Muscular Dystrophy
- Designing Effective Antisense Oligonucleotides for Exon Skipping
- Identification of Splicing Factors Involved in DMD Exon Skipping Events Using an In Vitro RNA Binding Assay
- The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy
- PMO Delivery SystemUsingBubble Liposomes and Ultrasound Exposurefor Duchenne Muscular Dystrophy Treatment
- Proton Nuclear Magnetic Resonance (1H NMR) Spectroscopy-Based Analysis of Lipid Components in Serum / Plasma of Patients with Duchenne Muscular Dystrophy (DMD)
- Test of Anti-Fibrotic Drugs in a Cellular Model of Fibrosis Based on Muscle-Derived Fibroblasts from Duchenne Muscular Dystrophy Patients
- Flow Cytometry-Defined CD49d Expression in Circulating T-Lymphocytes is a Biomarker for Disease Progression in Duchenne Muscular Dystrophy
- Advanced Methods to Study the Cross-Talk Between Fibro-Adipogenic Progenitors and Muscle Stem Cells
- AAV6 Vector Production and Purification for Muscle Gene Therapy
- From gRNA Identification to the Restoration of Dystrophin Expression: A Dystrophin Gene Correction Strategy for Duchenne Muscular Dystrophy Mutations Using the CRISPR-Induced Deletion Method.